Globus Medical (GMED) Tops Q2 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Globus Medical Reports Second Quarter 2018 Results
August 1, 2018 4:15 PM EDTAUDUBON, Pa., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the second quarter ended June 30, 2018.
Worldwide sales were $173.4 million, an increase of 13.8% as reportedSecond quarter net income was $45.0 million, an increase of 56.9%Diluted earnings per share (EPS) and non-GAAP EPS were $0.44Non-GAAP EPS increased 38.0% compared to second quarter of 2017Non-GAAP adjusted EBITDA was 34.3% of sales"The second quarter marks the third consecutive quarter of double-digit organic... More
